4.4 Article

Essential Continuous Glucose Monitoring Metrics: The Principal Dimensions of Glycemic Control in Diabetes

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Impact of a Novel Diabetes Support System on a Cohort of Individuals With Type 1 Diabetes Treated With Multiple Daily Injections: A Multicenter Randomized Study

Alessandro Bisio et al.

Summary: The study evaluated the impact of a CGM-based decision support system (DSS) in patients with type 1 diabetes (T1D) using multiple daily injections (MDI). The results suggest that the DSS is a feasible option for individuals using MDI, although further investigation is needed to determine the glycemic benefits associated with its use.

DIABETES CARE (2022)

Article Endocrinology & Metabolism

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

David C. Klonoff et al.

Summary: This study developed a composite index called GRI to assist clinicians in interpreting the quality of CGM data, based on metrics like blood glucose range, mean glucose, and coefficient of variation. The GRI consists of two main components related to hypoglycemia and hyperglycemia, which can be graphically displayed on a GRI Grid for tracking individual glycemic changes over time.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2022)

Article Endocrinology & Metabolism

One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology

Marc D. Breton et al.

Summary: In a real-world analysis of Control-IQ technology users, the study found that the technology demonstrated good glycemic improvements in different types of diabetes patients. Over the 12-month observation period, the level of time spent in automation remained high, and the time within the blood glucose control target range also increased.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Review Endocrinology & Metabolism

Quality of Glycemic Control: Assessment Using Relationships Between Metrics for Safety and Efficacy

David Rodbard

Summary: This review suggests that only two metrics are sufficient for monitoring patients or comparing different forms of management interventions: one for efficacy evaluation and one for safety evaluation. By analyzing the relationships between safety and efficacy metrics, sensitivity can be improved and the need for arbitrary scoring systems can be avoided, offering the advantage of simplicity in both concept and practice.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Article Endocrinology & Metabolism

Randomized Controlled Trial of Mobile Closed-Loop Control

Boris Kovatchev et al.

DIABETES CARE (2020)

Review Endocrinology & Metabolism

A Review of Continuous Glucose Monitoring-Based Composite Metrics for Glycemic Control

Michelle Nguyen et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2020)

Article Medicine, General & Internal

A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes

Marc D. Breton et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

S. A. Brown et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Editorial Material Endocrinology & Metabolism

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

Richard M. Bergenstal et al.

DIABETES CARE (2018)

Review Endocrinology & Metabolism

Metrics for glycaemic control - from HbA1c to continuous glucose monitoring

Boris P. Kovatchev

NATURE REVIEWS ENDOCRINOLOGY (2017)

Article Endocrinology & Metabolism

International Consensus on Use of Continuous Glucose Monitoring

Thomas Danne et al.

DIABETES CARE (2017)

Article Endocrinology & Metabolism

Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes

Boris Kovatchev et al.

DIABETES CARE (2016)

Letter Medicine, General & Internal

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

Richard M. Bergenstal et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Article Endocrinology & Metabolism

Closed- Loop Artificial Pancreas Systems: Engineering the Algorithms

Francis J. Doyle et al.

DIABETES CARE (2014)

Article Endocrinology & Metabolism

Glucose Variability Indices in Type 1 Diabetes: Parsimonious Set of Indices Revealed by Sparse Principal Component Analysis

Chiara Fabris et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2014)

Article Endocrinology & Metabolism

Optimal Sampling Intervals to Assess Long-Term Glycemic Control Using Continuous Glucose Monitoring

Dongyuan Xing et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2011)

Article Endocrinology & Metabolism

Statistical Tools to Analyze Continuous Glucose Monitor Data

William Clarke et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2009)

Article Endocrinology & Metabolism

Interpretation of Continuous Glucose Monitoring Data: Glycemic Variability and Quality of Glycemic Control

David Rodbard

DIABETES TECHNOLOGY & THERAPEUTICS (2009)

Article Endocrinology & Metabolism

A method for assessing quality of control from glucose profiles

N. R. Hill et al.

DIABETIC MEDICINE (2007)

Article Statistics & Probability

Sparse principal component analysis

Hui Zou et al.

JOURNAL OF COMPUTATIONAL AND GRAPHICAL STATISTICS (2006)